Cell-based Assays Market by Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User, and Region - Global Forecast to 2022 - Product Image

Cell-based Assays Market by Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User, and Region - Global Forecast to 2022

  • ID: 4332790
  • Report
  • Region: Global
  • 167 Pages
  • Markets and Markets
1 of 6
The Global Cell-Based Assays Market is Expected to Reach USD 19.92 Billion by 2022, at a CAGR of 8.4% from 2017 to 2022

FEATURED COMPANIES

  • Cell Biolabs, Inc.
  • Cisbio Bioassays
  • Danaher Corporation
  • Discoverx Corporation
  • General Electric Company
  • Lonza Group Ltd.
  • MORE

“Cell-based assays market projected to grow at a CAGR of 8.4% during the forecast period”

The global cell-based assays market is expected to reach USD 19.92 billion by 2022, at a CAGR of 8.4% from 2017 to 2022. The major factors driving this market are the growing funding and investments in R&D, the increasing prevalence of chronic disorders, rising drug discovery activity, and the advantages of cell-based assays over alternative technologies. On the other hand, the growth of this market is hindered to some extent due to the high cost of instruments and stringent regulatory policies

“Consumables to register the highest CAGR during the forecast period”

The cell-based assays market is classified on the basis of products into consumables, instruments, services and software. The consumables segment is further segmented into reagents, assay kits, microplates, cell lines, probes & labels and other consumables. The consumables segment is expected to grow at the highest rate during the forecast period. This is attributed to the effective and innovative products developed and launched by various players in the market. Such products are encouraging acceptance from consumers.

“Pharmaceutical and biotechnology companies to dominate the cell-based assays market during the forecast period”

The cell-based assays market is segmented by end users into pharmaceutical and biotechnology companies, academic and government institutions, contract research organizations, and other end users such as hospitals, clinical laboratories, and environmental monitoring laboratories. In 2017, pharmaceutical and biotechnology companies segment is expected to command the largest share and is also estimated to grow at the fastest rate as compared to the other segments. This positive growth can be attributed to the increasing adoption of cell-based assays for drug discovery by these end users, particularly in developed countries across North America and Europe.

“APAC is estimated to be the fastest growing regional segment in the global cell-based assays market during the forecast period”

Geographically, the cell-based assays market is dominated by North America, followed by Europe. The Asia-Pacific region is estimated to grow at the fastest rate which can be attributed to the increased investments in the healthcare sector, rising expenditure on healthcare along with increased coverage of health insurance, and a rise in disposable incomes especially in countries like China, Japan, and India.

The Primary Interviews Conducted for this Report can be Categorized as Follows:

  • By Company Type - Tier 1 - 25 %, Tier 2 - 35% and Tier 3 - 40%
  • By Designation - C level - 35%, Director level - 25%, Others - 40%
  • By Region - North America - 43%, Europe - 19%, APAC - 29%, RoW - 9%

The key players in the market are Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K), Thermo Fisher Scientific Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), BioTek Instruments, Inc. (U.S.), Lonza Group (U.S.), ProQinase GmbH (Germany), Charles River Laboratories, Inc (U.S.), Cisbio Bioassays (France), Miltenyi Biotec (Germany), Cell Biolabs, Inc. (U.S.), DiscoverX Corporation (U.S.), Marin Biologic Laboratories (U.S.), Biospherix, Ltd (U.S.), Essen BioScience Inc. (U.S.), Life Technologies Corporation (U.S.), BioAgilytix Labs. (U.S.), Enzo Life Sciences, Inc. (Switzerland), Aurelia Bioscience Ltd. (U.K. ), Selexis SA (U.S.), and QGel SA (Switzerland).

Research Coverage:

The report analyses the cell-based assays market by products, applications, end users, and regions. Apart from a comprehensive geographic & product analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise of product portfolios, developments, and strategies adopted by key players to maintain and increase their shares in the market. The market research data, current market size, and forecast of the future trends in the market will help established players as well as new entrants make necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the cell-based assays market.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned strategies to strengthen their market shares.

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the cell-based assays market
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the cell-based assays market
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the cell-based assays market
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various cell-based assays across geographies
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell-based assays market

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Cell Biolabs, Inc.
  • Cisbio Bioassays
  • Danaher Corporation
  • Discoverx Corporation
  • General Electric Company
  • Lonza Group Ltd.
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Cell-Based Assays Market: Premium Insights
4.1 Cell-Based Assays: Market Overview
4.2 Geographic Analysis: Global Market, By End User (2017)
4.3 Geographical Snapshot of the Global Market
4.4 Global Market, By Application, 2017 vs 2022

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Chronic Diseases
5.2.1.2 Growing Availability of Funds for Research
5.2.1.3 Growing Preference for Cell-Based Assays
5.2.1.4 Increasing Drug Discovery Activity
5.2.2 Restraint
5.2.2.1 High Cost of Instruments, Restrictions on Reagent Use
5.2.3 Opportunity
5.2.3.1 Asian Countries

6 Cell-Based Assays Market, By Product and Service
6.1 Introduction
6.2 Consumables
6.2.1 Reagents
6.2.2 Assay Kits
6.2.2.1 Reporter Gene Assays
6.2.2.2 Cell Growth Assays
6.2.2.3 Second Messenger Assays
6.2.2.4 Cell Death Assays
6.2.2.5 Other Assays
6.2.3 Microplates
6.2.4 Cell Lines
6.2.4.1 Immortalized Cell Lines
6.2.4.2 Primary Cell Lines
6.2.4.3 Stem Cell Lines
6.2.5 Probes and Labels
6.2.6 Other Consumables
6.3 Instruments
6.4 Services
6.5 Software

7 Cell-Based Assays Market, By Application
7.1 Introduction
7.2 Drug Discovery
7.3 Basic Research
7.4 Adme Studies
7.5 Predictive Toxicology
7.6 Other Applications

8 Cell-Based Assays Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Academic & Government Institutions
8.4 Contract Research Organizations
8.5 Other End Users

9 Cell-Based Assays Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 RoE
9.4 Asia
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia
9.5 Rest of the World

10 Competitive Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Vendor Dive Overview
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Benchmarking
10.4.1 Business Strategies Adopted By Major Players in the Cell-Based Assays Market (25 Players)
10.4.2 Analysis of Product Portfolio of Major Players in the Global Market (25 Players)

*Top 25 Companies Analysed for This Study are - Becton, Dickinson and Company. (U.S.), Cell Signaling Technology (U.S.), Danahar Corporation (U.S.), Cisbio Bioassays (France), Merck KGaA (Germany), Ge Healthcare (U.K), Discoverx Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Perkinelmer Inc. (U.S.), Promega Corporation (U.S.), Proqinase GmbH (Germany), Charles River Laboratories International, Inc. (U.S.), Marine Biological Laboratory (U.S.), Biospherix, Ltd. (U.S.), Essen Bioscience (U.S.), Miltenyi Biotec (Switzerland), Bioagilytix Labs. (U.S.), Enzo Life Sciences, Inc. (Switzerland), Lonza (Switzerland), Aurelia Bioscience Ltd. (U.K), Selexis Sa (U.S.), Life Technologies Corporation (U.S.), Cell Biolabs, Inc. (U.S.), Biotek Instruments, Inc. (U.S.), Qgel Sa (Switzerland)

11 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 Becton, Dickinson and Company
11.2 Danaher Corporation
11.3 Thermo Fisher Scientific Inc.
11.4 General Electric Company
11.5 Merck KGaA
11.6 Perkinelmer, Inc.
11.7 Charles River Laboratories, Inc.
11.8 Lonza Group Ltd.
11.9 Cell Signaling Technology, Inc.
11.10 Promega Corporation
11.11 Cisbio Bioassays
11.12 Cell Biolabs, Inc.
11.13 Discoverx Corporation

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details

List of Tables
Table 1 Increase in Cancer Patient Population, By Cancer Type
Table 2 Cell-Based Assays Market, By Product & Service, 2015–2022 (USD Million)
Table 3 Market for Consumables, By Type, 2015–2022 (USD Million)
Table 4 Market for Consumables, By Region, 2015–2022 (USD Million)
Table 5 Market for Reagents, By Region, 2015–2022 (USD Million)
Table 6 Market for Assay Kits, By Type, 2015–2022 (USD Million)
Table 7 Cell-Based Assays Market for Assay Kits, By Region, 2015–2022 (USD Million)
Table 8 Market for Reporter Gene Assays, By Region, 2015–2022 (USD Million)
Table 9 Market for Cell Growth Assays, By Region, 2015–2022 (USD Million)
Table 10 Market for Second Messenger Assays, By Region, 2015–2022 (USD Million)
Table 11 Market for Cell Death Assays, By Region, 2015–2022 (USD Million)
Table 12 Other Cell-Based Assays Market, By Region, 2015–2022 (USD Million)
Table 13 Market for Microplates, By Region, 2015–2022 (USD Million)
Table 14 Market for Cell Lines, By Region, 2015–2022 (USD Million)
Table 15 Market for Cell Lines, By Type, 2015–2022 (USD Million)
Table 16 Market for Immortalized Cell Lines, By Region, 2015–2022 (USD Million)
Table 17 Cell-Based Assays Market for Primary Cell Lines, By Region, 2015–2022 (USD Million)
Table 18 Market for Stem Cell Lines, By Region, 2015–2022 (USD Million)
Table 19 Market for Probes and Labels, By Region, 2015–2022 (USD Million)
Table 20 Market for Other Consumables, By Region, 2015–2022 (USD Million)
Table 21 Market for Instruments, By Region, 2015–2022 (USD Million)
Table 22 Cell-Based Assays Market for Services, By Region, 2015–2022 (USD Million)
Table 23 Market for Software, By Region, 2015–2022 (USD Million)
Table 24 Market, By Application, 2015–2022 (USD Million)
Table 25 Market for Drug Discovery, By Region, 2015–2022 (USD Million)
Table 26 Market for Basic Research, By Region, 2015–2022 (USD Million)
Table 27 Cell-Based Assays Market for Adme Studies, By Region, 2015–2022 (USD Million)
Table 28 Market for Predictive Toxicology, By Region, 2015–2022 (USD Million)
Table 29 Other Cell-Based Assay Applications Market, By Region, 2015–2022 (USD Million)
Table 30 Market Size, By End User, 2015–2022 (USD Million)
Table 31 Market Size for Pharmaceutical & Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 32 Market Size for Academic & Government Institutions, By Region, 2015–2022 (USD Million)
Table 33 Market Size for Contract Research Organizations, By Region, 2015–2022 (USD Million)
Table 34 Market Size for Other End Users, By Region, 2015–2022 (USD Million)
Table 35 Market, By Region, 2015–2022 (USD Million)
Table 36 North America: Cell-Based Assays Market, By Country, 2015–2022 (USD Million)
Table 37 North America: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 38 North America: Market, By Application, 2015–2022 (USD Million)
Table 39 North America: Market, By End User, 2015–2022 (USD Million)
Table 40 U.S.: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 41 U.S.: Market, By Application, 2015–2022 (USD Million)
Table 42 U.S.: Market, By End User, 2015–2022 (USD Million)
Table 43 Canada: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 44 Canada: Market, By Application, 2015–2022 (USD Million)
Table 45 Canada: Market, By End User, 2015–2022 (USD Million)
Table 46 Europe: Cell-Based Assays Market, By Country, 2015–2022 (USD Million)
Table 47 Europe: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 48 Europe: Market, By Application, 2015–2022 (USD Million)
Table 49 Europe: Market, By End User, 2015–2022 (USD Million)
Table 50 Germany: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 51 Germany: Market, By Application, 2015–2022 (USD Million)
Table 52 Germany: Market, By End User, 2015–2022 (USD Million)
Table 53 France: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 54 France: Market, By Application, 2015–2022 (USD Million)
Table 55 France: Market, By End User, 2015–2022 (USD Million)
Table 56 U.K.: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 57 U.K.: Market, By Application, 2015–2022 (USD Million)
Table 58 U.K.: Market, By End User, 2015–2022 (USD Million)
Table 59 Italy: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 60 Italy: Market, By Application, 2015–2022 (USD Million)
Table 61 Italy: Market, By End User, 2015–2022 (USD Million)
Table 62 Spain: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 63 Spain: Market, By Application, 2015–2022 (USD Million)
Table 64 Spain: Market, By End User, 2015–2022 (USD Million)
Table 65 RoE: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 66 RoE: Market, By Application, 2015–2022 (USD Million)
Table 67 RoE: Market, By End User, 2015–2022 (USD Million)
Table 68 Asia: Cell-Based Assays Market, By Country, 2015–2022 (USD Million)
Table 69 Asia: Market Size, By Product & Service, 2015–2022 (USD Million)
Table 70 Asia: Market, By Application, 2015–2022 (USD Million)
Table 71 Asia: Market, By End User, 2015–2022 (USD Million)
Table 72 China: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 73 China: Market, By Application, 2015–2022 (USD Million)
Table 74 China: Market, By End User, 2015–2022 (USD Million)
Table 75 Japan: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 76 Japan: Market, By Application, 2015–2022 (USD Million)
Table 77 Japan: Market, By End User, 2015–2022 (USD Million)
Table 78 India: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 79 India: Market, By Application, 2015–2022 (USD Million)
Table 80 India: Market, By End User, 2015–2022 (USD Million)
Table 81 RoA: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 82 RoA: Market, By Application, 2015–2022 (USD Million)
Table 83 RoA: Market, By End User, 2015–2022 (USD Million)
Table 84 RoW: Cell-Based Assays Market Size, By Product & Service, 2015–2022 (USD Million)
Table 85 RoW: Market, By Application, 2015–2022 (USD Million)
Table 86 RoW: Market, By End User, 2015–2022 (USD Million)

List of Figures
Figure 1 Global Cell-Based Assays Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Global Market: Bottom-Up Approach
Figure 5 Global Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Market, By Product & Service, 2017 vs 2022 (USD Billion)
Figure 8 Global Market, By Application, 2017 vs 2022 (USD Billion)
Figure 9 Global Market, By End User, 2017 vs 2022 (USD Billion)
Figure 10 Geographic Snapshot of the Global Market
Figure 11 Global Cell-Based Assays Market to Witness Moderate Growth During the Forecast Period
Figure 12 Pharmaceutical and Biotechnological Companies are Expected to Account for the Largest Share of the Global Market in 2017
Figure 13 Asia to Register the Highest Growth During the Forecast Period
Figure 14 Drug Discovery Segment Will Continue to Dominate the Global Market in 2022
Figure 15 Global Market: Drivers, Restraint, and Opportunities
Figure 16 Consumables to Dominate the Market During 2017–2022
Figure 17 Drug Discovery Will Continue to Dominate the Global Market During the Forecast Period
Figure 18 Pharmaceutical & Biotechnology Companies to Dominate the Global Market During the Forecast Period
Figure 19 Asian Cell-Based Assays Market to Grow at the Highest Rate During the Forecast Period
Figure 20 Asian Market to Register the Higher CAGR During Forecast Period
Figure 21 North America: Market Snapshot
Figure 22 Pharmaceutical & Biotechnology Companies to Account for the Largest Share of the End-User Market in North America
Figure 23 Consumables, the Largest Segment in the U.S. Market, By Product & Service, in 2017
Figure 24 Drug Discovery Application Segment to Dominate the Canadian Market in 2017
Figure 25 Contract Research Organizations, the Fastest-Growing End-User Segment in Europe
Figure 26 Consumables Estimated to Be the Largest Product & Service Segment in the German Assays Market in 2017
Figure 27 Drug Discovery to Dominate the French Cell-Based Assays Market, By Application, in 2017
Figure 28 Consumables, the Largest Product & Service Segment in the U.K. Market in 2017
Figure 29 Pharmaceutical & Biotechnology Companies to Be the Largest End-User Segment in the Italian Market, 2017
Figure 30 Drug Discovery, the Largest Application Segment in the Spanish Market in 2017
Figure 31 RoE Market, By End User: Pharmaceutical & Biotechnology Companies Estimated to Hold Largest Share in 2017
Figure 32 Asia: Market Snapshot
Figure 33 Consumables to Account for the Largest Product Segment of the Market in Asia in 2017
Figure 34 Pharmaceutical & Biotechnology Companies to Account for the Largest End-User Segment of the Market in China in 2017
Figure 35 Consumables to Account for the Largest Share of the Cell-Based Assays Market, By Product & Service, in Japan, 2017
Figure 36 Drug Discovery to Account for the Largest Application of the Global Market in India in 2017
Figure 37 Pharmaceutical & Biotechnology Companies to Account for the Largest End-User of the Market in RoA in 2017
Figure 38 Consumables to Account for the Largest Share of the Market in RoW in 2017
Figure 39 Global Cell-Based Assays Market Share Analysis, By Key Player, 2016
Figure 40 Dive Chart
Figure 41 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 42 Danaher Corporation: Company Snapshot (2016)
Figure 43 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 44 General Electric Company: Company Snapshot (2016)
Figure 45 Merck KGaA: Company Snapshot (2016)
Figure 46 Perkinelmer, Inc.: Company Snapshot (2017)
Figure 47 Charles River Laboratories, Inc.: Company Snapshot (2016)
Figure 48 Lonza Group Ltd.: Company Snapshot (2016)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Becton, Dickinson and Company
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories, Inc.
  • Cisbio Bioassays
  • Danaher Corporation
  • Discoverx Corporation
  • General Electric Company
  • Lonza Group Ltd.
  • Merck KGaA
  • Perkinelmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll